![Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells | Science Translational Medicine Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3002346/asset/67462d57-e430-4585-b96c-dd72ac74521f/assets/graphic/3-89ra58-f1.jpeg)
Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells | Science Translational Medicine
![Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application](https://www.frontiersin.org/files/Articles/429744/fphar-09-01520-HTML/image_m/fphar-09-01520-g001.jpg)
Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
![Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye | Scientific Reports Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-40404-0/MediaObjects/41598_2019_40404_Fig1_HTML.png)